These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4825301)

  • 1. Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in man.
    Eaton RP; Schade DS
    Metabolism; 1974 May; 23(5):445-54. PubMed ID: 4825301
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of clofibrate on arginine-induced insulin and glucagon secretion.
    Eaton RP
    Metabolism; 1973 Jun; 22(6):763-7. PubMed ID: 4350845
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment.
    Tiengo A; Muggeo M; Assan R; Fedele D; Crepaldi G
    Metabolism; 1975 Aug; 24(8):901-14. PubMed ID: 1143089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.
    Fenderson RW; Sekowski I; Mohan C; Deutsch S; Benjamin F; Samuel P
    Am J Clin Nutr; 1974 Jan; 27(1):22-8. PubMed ID: 4809201
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of clofibrate treatment on arginine-induced insulin secretion in endogenous hypertriglyceridemia.
    Fedele D; Tiengo A; Muggeo M; Nosadini R; Crepaldi G
    Atherosclerosis; 1976; 25(2-3):191-8. PubMed ID: 1008908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of changes in plasma levels of free fatty acids on plasma glucagon, insulin, and growth hormone in man.
    Hicks BH; Taylor CI; Vij SK; Pek S; Knopf RF; Floyd JC; Fajans SS
    Metabolism; 1977 Sep; 26(9):1011-23. PubMed ID: 895532
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of short-term clofibrate administration on glucose tolerance and insulin secretion in patients with chemical diabetes or hypertriglyceridemia.
    Ferrari C; Frezzati S; Romussi M; Bertazzoni A; Testori GP; Antonini S; Paracchi A
    Metabolism; 1977 Feb; 26(2):129-39. PubMed ID: 834147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of clofibrate in insulin-dependent ketosis-prone diabetic man.
    Schade DS; Eaton RP; George S; Conway M; Kaminsky N; Sivinski J
    Metabolism; 1978 Apr; 27(4):461-8. PubMed ID: 416322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of insulin and glucagon secretions in severely burned patients.
    Shuck JM; Eaton P; Shuck LW; Wachtel TL; Schade DS
    J Trauma; 1977 Sep; 17(9):706-13. PubMed ID: 894760
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women. III. Medroxyprogesterone acetate.
    Beck P; Zimmerman DE; Eaton RP
    Metabolism; 1977 Nov; 26(11):1193-8. PubMed ID: 909395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women: I-Lipid physiology.
    Beck P; Eaton RP; Arnett DM; Alsever RN
    Metabolism; 1975 Sep; 24(9):1055-65. PubMed ID: 1152675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese diabetics].
    Cucinotta D; Quartarone M; Saitta A; Sardo A; Squadrito G
    Boll Soc Ital Biol Sper; 1978 Nov; 54(22):2290-6. PubMed ID: 754729
    [No Abstract]   [Full Text] [Related]  

  • 13. Somatostatin as a tool in studies of basal carbohydrate and lipid metabolism in man: modifications of glucagon and insulin release.
    Christensen SE; Hansen AP; Iversen J; Lundbaek K; Orskov H; Seyer-Hansen K
    Scand J Clin Lab Invest; 1974 Dec; 34(4):321-5. PubMed ID: 4460228
    [No Abstract]   [Full Text] [Related]  

  • 14. Responses of plasma glucose, free fatty acids, glucagon and insulin to synthalin A by Gallus domesticus.
    Langslow DR; Freeman BM; Buchanan KD
    Comp Biochem Physiol A Comp Physiol; 1973 Nov; 46(3):437-45. PubMed ID: 4148980
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of short-term administration of clofibrate on insulin and glucagon response to protein ingestion in man.
    Fery F; Balasse EO
    Arch Int Pharmacodyn Ther; 1978 Oct; 235(2):341-50. PubMed ID: 736705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese patients].
    Cucinotta D; Quartarone M; Di Cesare E; Longo G; Squadrito G
    Boll Soc Ital Biol Sper; 1978 Nov; 54(22):2283-9. PubMed ID: 754728
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced postglucose hypophosphatemia during starvation therapy of obesity.
    Corredor DG; Sabeh G; Mendelsohn LV; Wasserman RE; Sunder JH; Danowski TS
    Metabolism; 1969 Sep; 18(9):754-63. PubMed ID: 5343867
    [No Abstract]   [Full Text] [Related]  

  • 18. Somatostatin modulation of pancreatic glucagon, insulin, glucose and free fatty acids following beta-adrenergic stimulation.
    Raptis S; Escobar-Jimenez F; Rosenthal J; Ditschuneit HH; Pfeiffer EF
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1088-93. PubMed ID: 874045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the catabolic activity of glucagon by endogenous insulin secretion in obese man.
    Schade DS; Eaton PR
    Acta Diabetol Lat; 1977; 14(1-2):62-72. PubMed ID: 596102
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effect of clofibrate on arginine-induced insulin secretion in chemical diabetes.
    Pontiroli AE; Viberti G; Pozza G
    Acta Diabetol Lat; 1976; 13(3-4):107-10. PubMed ID: 1020607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.